Search Results - "Creger, R J"

Refine Results
  1. 1

    Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? by Bobak, D, Arfons, L M, Creger, R J, Lazarus, H M

    Published in Bone marrow transplantation (Basingstoke) (01-12-2008)
    “…Clostridium difficile is the most common cause of nosocomial diarrhea in the United States and Europe, and is a cause of significant morbidity and mortality…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? by NAEEM, N, REED, M. D, CREGER, R. J, YOUNGNER, S. J, LAZARUS, H. M

    Published in Bone marrow transplantation (Basingstoke) (01-01-2006)
    “…We critically reviewed published English language literature and concluded that from 1998 onward the survival of hematopoietic stem cell transplant (SCT)…”
    Get full text
    Journal Article
  4. 4

    Pre-mobilization therapy blood CD34 cell count predicts the likelihood of successful hematopoietic stem cell mobilization by FU, P, BAGAI, R. K, LAZARUS, H. M, MEYERSON, H, KANE, D, FOX, R. M, CREGER, R. J, COOPER, B. W, GERSON, S. L, LAUGHLIN, M. J, KOC, O. N

    Published in Bone marrow transplantation (Basingstoke) (01-08-2006)
    “…We examined pre-mobilization blood CD34+ cell count to predict ability to mobilize adequate peripheral blood progenitor cells (PBPC) in 106 cancer patients and…”
    Get full text
    Journal Article
  5. 5

    Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile by Fields, K K, Elfenbein, G J, Lazarus, H M, Cooper, B W, Perkins, J B, Creger, R J, Ballester, O F, Hiemenz, J H, Janssen, W E, Zorsky, P E

    Published in Journal of clinical oncology (01-02-1995)
    “…A phase I dose-escalation study of ifosfamide, carboplatin, and etoposide (ICE) with autologous stem-cell rescue (ASCR) was conducted to determine the…”
    Get more information
    Journal Article
  6. 6

    Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation by Fu, P, van Heeckeren, W.J, Wadhwa, P.D, Bajor, D.J, Creger, R.J, Xu, Z, Cooper, B.W, Laughlin, M.J, Gerson, S.L, Koç, O.N, Lazarus, H.M

    Published in Contemporary clinical trials (01-03-2008)
    “…Abstract Evaluation of time to event outcomes usually is examined by the Kaplan–Meier method and Cox proportional hazards models. We developed a modified…”
    Get full text
    Journal Article
  7. 7

    Lowering the Prophylactic Platelet Transfusion Threshold: a Prospective Analysis by Lawrence, Jeffry B., Yomtovian, Roslyn A., Hammons, Terry, Masarik, Susan R., Chongkolwatana, Viroje, Creger, Richard J., Manka, Agnes, Lazarus, Hillard M.

    Published in Leukemia & lymphoma (2001)
    “…The 20 × 109/L threshold for prophylactic platelet transfusion may be unnecessarily high. Few prospective studies, however, in which other trigger values were…”
    Get full text
    Journal Article
  8. 8

    Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation by Espinosa, M T, Fox, R, Creger, R J, Lazarus, H M

    Published in Transfusion (Philadelphia, Pa.) (01-09-1996)
    “…Peripheral blood progenitor cells (PBPCs) rather than bone marrow are used increasingly to provide hematologic reconstitution when transfused after…”
    Get more information
    Journal Article
  9. 9

    High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma by Lazarus, H M, Crilley, P, Ciobanu, N, Creger, R J, Fox, R M, Shina, D C, Bulova, S I, Gucalp, R, Cooper, B W, Topolsky, D

    Published in Journal of clinical oncology (01-11-1992)
    “…We determined the toxicity and efficacy of a new preparative autologous bone marrow transplantation (ABMT) regimen in patients with relapsed or refractory…”
    Get more information
    Journal Article
  10. 10

    Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management by Iqbal, M, Creger, R J, Fox, R M, Cooper, B W, Jacobs, G, Stellato, T A, Lazarus, H M

    Published in Bone marrow transplantation (Basingstoke) (01-04-1996)
    “…Hepatic dysfunction is common in patients who receive intensive chemotherapy and it is important to determine the etiology in order to institute appropriate…”
    Get more information
    Journal Article
  11. 11

    Contamination during in vitro processing of bone marrow for transplantation: clinical significance by Lazarus, H M, Magalhaes-Silverman, M, Fox, R M, Creger, R J, Jacobs, M

    Published in Bone marrow transplantation (Basingstoke) (01-03-1991)
    “…We determined the prevalence and clinical significance of positive microbiologic cultures obtained from 194 consecutive bone marrow harvests intended for…”
    Get more information
    Journal Article
  12. 12

    High-dose cyclophosphamide-induced myocardial damage during BMT: assessment by positron emission tomography by Gardner, S F, Lazarus, H M, Bednarczyk, E M, Creger, R J, Miraldi, F D, Leisure, G, Green, J A

    Published in Bone marrow transplantation (Basingstoke) (01-08-1993)
    “…Despite its potential to cause myocardial damage, high-dose CY in doses up to 200 mg/kg is an integral part of preparative regimens for BMT. Conventional…”
    Get more information
    Journal Article
  13. 13

    Lack of Utility of the Lysis-Centrifugation Blood Culture Method for Detection of Fungemia in Immunocompromised Cancer Patients by CREGER, R. J, WEEMAN, K. E, JACOBS, M. R, MORRISSEY, A, PARKER, P, FOX, R. M, LAZARUS, H. M

    Published in Journal of Clinical Microbiology (01-01-1998)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    Corynebacterium striatum: A Diphtheroid with Pathogenic Potential by Watkins, David A., Chahine, Antoine, Creger, Richard J., Jacobs, Michael R., Lazarus, Hillard M.

    Published in Clinical infectious diseases (01-07-1993)
    “…Although nondiphtherial corynebacteria are ubiquitous in nature and commonly colonize the skin and mucous membranes of humans, they rarely account for clinical…”
    Get full text
    Journal Article
  15. 15

    Acute cholecystitis after autologous bone marrow transplantation for acute myeloid leukemia by Kuttah, L, Weber, F, Creger, R J, Fox, R M, Cooper, B W, Jacobs, G, Lazarus, H M

    Published in Annals of oncology (01-03-1995)
    “…We investigated the incidence of acute cholecystitis in patients with acute myeloid leukemia (AML) undergoing autologous bone marrow transplantation in…”
    Get more information
    Journal Article
  16. 16

    Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies by Crilley, P, Lazarus, H, Topolsky, D, Ciobanu, N, Creger, R J, Fox, R M, Bulova, S I, Shina, D C, Gucalp, R, Cooper, B W

    Published in Seminars in oncology (01-08-1993)
    “…Most bone marrow transplantation preparative regimens use total body irradiation as one component. Recently, however, two non-total body irradiation containing…”
    Get more information
    Journal Article
  17. 17

    Reliability of automated platelet counts: comparison with manual method and utility for prediction of clinical bleeding by Lawrence, J B, Yomtovian, R A, Dillman, C, Masarik, S R, Chongkolwatana, V, Creger, R J, Manka, A, Hammons, T, Lazarus, H M

    Published in American journal of hematology (01-04-1995)
    “…The 20 x 10(9)/L (20,000/microliters) threshold for prophylactic platelet transfusion may be unnecessarily high. The widespread use of this threshold may…”
    Get more information
    Journal Article
  18. 18

    Phase I trial of high-dose etoposide, high-dose cisplatin, and reinfusion of autologous bone marrow for lung cancer by Lazarus, H M, Spitzer, T R, Creger, R J

    Published in American journal of clinical oncology (01-04-1990)
    “…We undertook a phase I trial using fixed-dose cisplatin, escalating doses of etoposide, and reinfusion of previously obtained autologous bone marrow in 29…”
    Get more information
    Journal Article
  19. 19

    Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs by KING, C. H, CREGER, R. J, ELLNER, J. J

    Published in Antimicrobial Agents and Chemotherapy (01-03-1985)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  20. 20

    Delayed, transient encephalopathy after marrow transplantation : case reports and MRI findings in four patients by TAHSILDAR, H. I, REMLER, B. F, CREGER, R. J, COOPER, B. W, SNODGRASS, S. M, TARR, R. W, LAZARUS, H. M

    Published in Journal of neuro-oncology (01-03-1996)
    “…Subacute encephalopathy developed in four patients within one to two months after undergoing high-dose chemotherapy and bone marrow transplantation or…”
    Get full text
    Journal Article